A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
Clinical trial NCT00626197 · TERMINATED
Trial details
- NCT number
- NCT00626197
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-15
- Primary completion
- 2009-10-19
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.